The Relative Strength (RS) Rating for Veeva Systems stock climbed into a higher percentile Thursday, as it got a lift from 67 to 72.
When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.
IBD's proprietary rating identifies market leadership with a 1 (worst) to 99 (best) score. The rating shows how a stock's price movement over the trailing 52 weeks compares to all the other stocks in our database.
Decades of market research shows that the best stocks often have an RS Rating of at least 80 as they begin their biggest runs. See if Veeva Systems stock can continue to rebound and clear that threshold.
Looking For The Best Stocks To Buy And Watch? Start Here
Is Veev Systems Stock A Buy?
While now is not an ideal time to invest, see if the medical software stock is able to form a chart pattern and break out. Read "Looking For The Next Big Stock Market Winners? Start With These 3 Steps" for more tips.
The medical software firm reported -8% earnings growth in the latest quarterly report. Sales gains came in at 4%. The next quarterly results are expected on or around Aug. 30.
Veeva Systems stock earns the No. 3 rank among its peers in the Computer Software-Medical industry group. Veeva Systems and Health Catalyst are also among the group's highest-rated stocks.
